KLDO (Kaleido Biosciences) Other Financing: $0.15 Mil (TTM As of Dec. 2021)


What is Kaleido Biosciences Other Financing?

Kaleido Biosciences KLDO -99.00% Other Financing is $0.15 Mil as of Dec. 2021.

Kaleido Biosciences's Other Financing for the three months ended in Dec. 2021 was $0.00 Mil.

Kaleido Biosciences's Other Financing for the trailing twelve months (TTM) ended in Dec. 2021 was $0.15 Mil.

Kaleido Biosciences Other Financing Historical Data

* Premium members only.

The historical data trend for Kaleido Biosciences's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences Other Financing Chart

Kaleido Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Other Financing
Get a 7-Day Free Trial 3.02 -1.72 -0.53 2.71 0.11

Kaleido Biosciences Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.17 -0.02 0.00 0.00

Kaleido Biosciences Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $0.15 Mil mean?
Kaleido Biosciences (KLDO) has a Other Financing of $0.15 Mil as of Dec. 2021. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Kaleido Biosciences and its competitors.
Is Kaleido Biosciences' Other Financing too high?
Kaleido Biosciences' current Other Financing is $0.15 Mil.
How does Kaleido Biosciences' Other Financing compare to NPTX and GSTC?
Kaleido Biosciences' Other Financing of $0.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Kaleido Biosciences and its competitors. Kaleido Biosciences's current Other Financing is $0.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaleido Biosciences stock overvalued right now?
Kaleido Biosciences (KLDO) has a current Other Financing of $0.15 Mil. The current Other Financing is $0.15 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Kaleido Biosciences (KLDO), the current Other Financing is $0.15 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kaleido Biosciences Business Description

Address 65 Hayden Avenue, Lexington, MA, USA, 02421
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.